Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
Kymera Therapeutics (KYMR) - P/B ratio
P/B ratio as of May 2024 : 5.64
According to Kymera Therapeutics's latest financial reports the company has a price-to-book ratio of 5.64.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Kymera Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.58 | 28.02% |
| 2022-12-31 | 2.79 | -60.64% |
| 2021-12-31 | 7.10 | -26.9% |
| 2020-12-31 | 9.71 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -49.21% | 🇺🇸 USA |